Induction and Maintenance of Castration After Subcutaneous Injections of Triptorelin Pamoate in Patients With Prostate Cancer

Efficacy and Safety of a Triptorelin 6-month Formulation in Patients With Advanced Prostate Cancer

NCT00751790 ·Status: COMPLETED ·Phase: PHASE3

Study to Assess the Efficacy of Brachytherapy With or Without Hormone Therapy, Using Triptorelin 22.5mg in Patients With Recurrence of Prostate Cancer

NCT01374087 ·Status: TERMINATED ·Phase: PHASE2

Effect of Triptorelin (Decapeptyl®) 22.5 mg on Two Biomarkers in Patients With Advanced Prostate Cancer

NCT01020448 ·Status: COMPLETED ·Phase: PHASE3

Effects of Triptorelin Pamoate 6-month When Given to Adult Chinese Participants With Advanced Cancer in the Prostate

NCT05590793 ·Status: COMPLETED ·Phase: PHASE3

Study to Assess the Non-inferiority of Pamorelin® 11,25mg SC Injected Versus Pamorelin® 11,25mg IM Injected in Patients Suffering From Advanced Prostate Cancer (PAMOJECT)

NCT00444639 ·Status: TERMINATED ·Phase: PHASE2

Efficacy, Safety, and Pharmacokinetics of FP-014, 11.25 mg in Patients With Advanced Prostate Cancer

NCT06795178 ·Status: WITHDRAWN ·Phase: PHASE3

A Long-term Observational Study Cohort in Patients With Advanced Prostate Cancer

NCT01383863 ·Status: COMPLETED

Efficacy, Safety, and Pharmacokinetics of FP-014, 22.5 mg in Patients With Advanced Prostate Cancer

NCT06795191 ·Status: WITHDRAWN ·Phase: PHASE3

177Lu-PSMA-I&T for Metastatic Castration-Resistant Prostate Cancer

NCT05204927 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3

A Proof of Concept Study of Maintenance Therapy With Tasquinimod in Patients With Metastatic Castrate-resistant Prostate Cancer Who Are Not Progressing After a First Line Docetaxel Based Chemotherapy

NCT01732549 ·Status: TERMINATED ·Phase: PHASE2

Study To Assess Renewal Of Treatment In Patients Recently Diagnosed With Prostate Cancer

NCT02238366 ·Status: COMPLETED

Investigation of Early Hormonotherapy Efficacy of Prostate Cancer

NCT00375687 ·Status: UNKNOWN ·Phase: NA

Hormone Therapy in Treating Patients With Advanced Prostate Cancer

NCT00003026 ·Status: COMPLETED ·Phase: PHASE3

A Trial of Triamcinolone With a GnRH Analog for Castration Resistant Prostate Cancer

NCT07161778 ·Status: COMPLETED ·Phase: PHASE2

Short Versus Long-term Androgen Deprivation Therapy With Salvage Radiotherapy in Prostate Cancer. URONCOR 0624

NCT05781217 ·Status: RECRUITING ·Phase: PHASE3

GP Extended Action Triptorelin

NCT01673984 ·Status: TERMINATED ·Phase: PHASE4

Triptorelin and Radiation Therapy in Treating Patients Who Have Undergone Surgery for Intermediate-Risk Stage III or Stage IV Prostate Cancer

NCT00667069 ·Status: COMPLETED ·Phase: PHASE3

A Study to Observe Demography and the Outcome of Prostate Cancer Patients Treated With 6-month Triptorelin Formulation in Italy

NCT05759273 ·Status: COMPLETED

Treatment of Aggressive Prostate Cancer in Real Life: Initiation, Schedule and Management of Triptorelin Treatment.

NCT04593420 ·Status: COMPLETED

Trilostane for Androgen-Independent Prostate Cancer

NCT00181597 ·Status: COMPLETED ·Phase: PHASE2

A Phase 2 Study to Investigate the Clinical Activity of IPI-504 in Patients With Hormone-resistant Prostate Cancer

NCT00564928 ·Status: COMPLETED ·Phase: PHASE2

Randomized Crossover Trial to Assess the Tolerability of Gonadotropin Releasing Hormone (GnRH) Analogue Administration

NCT01161563 ·Status: COMPLETED ·Phase: PHASE4

Bipolar Androgen-based Therapy for Prostate Cancer (BAT)

NCT01750398 ·Status: COMPLETED ·Phase: PHASE2

Oral VT-464 in Patients With Castration-Resistant Prostate Cancer Previously Treated With Enzalutamide, Androgen Receptor Positive Triple-Negative Breast Cancer Patients, and Men With ER Positive Breast Cancer

NCT02130700 ·Status: COMPLETED ·Phase: PHASE2

Impact of Hormonal Therapy on Prostate Cancer Recurrence After Radical Prostatectomy

NCT05169112 ·Status: RECRUITING ·Phase: PHASE3